Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. — Natural Product Compound Library | Innovative Drug Discovery | Spectral Intelligence | Micro-ED Analysis

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. Healthy Roots Biotechnology (Shenzhen) Co., Limited Joint Development

中文 EN

Home

Products

NP Database

Services

Tech Insights

About

Contact

中文 EN

Plant Sources

Structural Classes

Microbial Sources

Flagship Varieties

Synthetic Compounds

CAS No.	NAME	Molecular Formula	Molecular Weight	Purity	Price	2D Structure
312747-21-0	N-(6-nitro-1,3-benzothiazol-2-yl)cyclohexanecarboxamide C1CCC(CC1)C(=O)NC2=NC3=C(S2)C=C(C=C3)[N+](=O)[O-]	C₁₄H₁₅N₃O₃S	305.35	98%	Click to inquire
478482-75-6	GSK-3 Inhibitor II C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3	C₁₄H₁₀IN₃OS	395.22	98%	Click to inquire
2244579-87-9	CB2R Pam CC1=C(C(=O)N(C=C1Br)CC2=CC=C(C=C2)F)NC(=O)C3CCCCCC3	C₂₁H₂₄BRFN₂O₂	435.3	98%	Click to inquire
64821-19-8	M30 (dihydrochloride) CN(CC#C)CC1=C2C=CC=NC2=C(C=C1)O.Cl.Cl	C₁₄H₁₆Cl₂N₂O	299.2	98%	Click to inquire
1428652-17-8	Baxdrostat CCC(=O)NC1CCCC2=C1C=NC=C2C3=CC4=C(C=C3)N(C(=O)CC4)C	C₂₂H₂₅N₃O₂	363.5	98%	Click to inquire
1391076-61-1	4-[[(2R)-1-(1-benzothiophene-3-carbonyl)-2-methylazetidine-2-carbonyl]-[(3-chlorophenyl)methyl]amino]butanoic acid CC1(CCN1C(=O)C2=CSC3=CC=CC=C32)C(=O)N(CCCC(=O)O)CC4=CC(=CC=C4)Cl	C₂₅H₂₅ClN₂O₄S	485.0	98%	Click to inquire
1638611-48-9	5-Chloro-2-methoxy-N-(4-(N-methylsulfamoyl)phenethyl)benzamide CNS(=O)(=O)C1=CC=C(C=C1)CCNC(=O)C2=C(C=CC(=C2)Cl)OC	C₁₇H₁₉ClN₂O₄S	382.9	95%	Click to inquire
1375060-02-8	N'-{(E)-[4-(diethylamino)-2-hydroxyphenyl]methylidene}pyridine-3-carbohydrazide CCN(CC)C1=CC(=C(C=C1)C=NNC(=O)C2=CN=CC=C2)O	C₁₇H₂₀N₄O₂	312.37	98%	Click to inquire
1638956-60-1	(2Z)-6-hydroxy-2-(2,3,4-trimethoxybenzylidene)-1-benzofuran-3(2H)-one COC1=C(C(=C(C=C1)C=C2C(=O)C3=C(O2)C=C(C=C3)O)OC)OC	C₁₈H₁₆O₆	328.3	98%	Click to inquire
160627-57-6	4-Bromo-N-(morpholin-4-yl-carbothioyl)benzamide C1COCCN1C(=S)NC(=O)C2=CC=C(C=C2)Br	C₁₂H₁₃BRN₂O₂S	329.21	98%	Click to inquire

N-(6-nitro-1,3-benzothiazol-2-yl)cyclohexanecarboxamide

C₁₄H₁₅N₃O₃S 305.35

GSK-3 Inhibitor II

GSK3β inhibitor II

C₁₄H₁₀IN₃OS 395.22

C₂₁H₂₄BRFN₂O₂ 435.3

M30 (dihydrochloride)

MAO-IN-M30 dihydrochloride

C₁₄H₁₆Cl₂N₂O 299.2

C₂₂H₂₅N₃O₂ 363.5

4-[[(2R)-1-(1-benzothiophene-3-carbonyl)-2-methylazetidine-2-carbonyl]-[(3-chlorophenyl)methyl]amino]butanoic acid

C₂₅H₂₅ClN₂O₄S 485.0

5-Chloro-2-methoxy-N-(4-(N-methylsulfamoyl)phenethyl)benzamide

C₁₇H₁₉ClN₂O₄S 382.9

N'-{(E)-[4-(diethylamino)-2-hydroxyphenyl]methylidene}pyridine-3-carbohydrazide

C₁₇H₂₀N₄O₂ 312.37

(2Z)-6-hydroxy-2-(2,3,4-trimethoxybenzylidene)-1-benzofuran-3(2H)-one

C₁₈H₁₆O₆ 328.3

4-Bromo-N-(morpholin-4-yl-carbothioyl)benzamide

4-Bromo-N-(morpholine-4-carbonothioyl)benzamide

C₁₂H₁₃BRN₂O₂S 329.21

< Previous 1 2 3 4 5 6 7 8 9 10 ... (Current page 15736) 16106 Next >

All products and services are for scientific research only. They may not be used for human administration, nor are they supplied to individual consumers.

Address: Room B410, Virtual University Park Key Laboratory Building, No. 1 Yuexing 2nd Road, High-Tech Zone Community, Yuehai Subdistrict, Nanshan District, Shenzhen

Phone: 400-856-5689

Email: kehuaai@kehuaai.com

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd.

ICP Record No.: 粤ICP备2024241782号